Medicare Enrolled

Dr. Shahla Ali, M.D

Psychiatry · Allen, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1774 W MCDERMOTT DR, Allen, TX 75013
4693402777
Registered in NPPES since 2010
NPI: 1740505957 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ali

Dr. Shahla Ali is a psychiatry specialist in Allen, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Ali performed 1,128 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Ali received a total of $50,217 from 41 pharmaceutical and/or device companies across 716 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ Top 9% volume in TX $50,217 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,128
Medicare services
Top 9% in TX for psychiatry
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
286 $139 $475
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
264 $89 $150
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
193 $50 $101
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
134 $63 $149
Psychotherapy session, 1 hour
A one-hour psychotherapy session involving talk therapy to address mental health concerns.
129 $110 $171
Psychiatric services complicated by communication factor
Psychiatric evaluation or treatment provided when communication barriers complicate the interaction between the provider and the patient.
72 $11 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
50 $117 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$50,217
Total received (2018-2024)
Avg $7,174/year across 7 years
Top 3% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
716
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,572
2023
$15,241
2022
$15,932
2021
$8,752
2020
$7,105
2019
$1,514
2018
$102

Payments by company (2024)

ABBVIE INC.
$391
Neuronetics, Inc.
$287
Corium, LLC
$247
Neurocrine Biosciences, Inc.
$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$173
Teva Pharmaceuticals USA, Inc.
$49
Bausch Health US, LLC
$46
Otsuka America Pharmaceutical, Inc.
$41
Lundbeck LLC
$30
Janssen Pharmaceuticals, Inc
$29
Alkermes, Inc.
$21
Azurity Pharmaceuticals, Inc.
$16
Noven Therapeutics, LLC
$15
Tris Pharma Inc
$14
Top 3 companies account for 58.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$33,433
Neuronetics, Inc.
$3,959
Janssen Scientific Affairs, LLC
$1,950
Sunovion Pharmaceuticals Inc.
$1,333
AbbVie Inc.
$1,258
Otsuka America Pharmaceutical, Inc.
$1,073
ABBVIE INC.
$822
Johnson & Johnson Health Care Systems Inc.
$585
Corium, LLC
$549
Lundbeck LLC
$547
Supernus Pharmaceuticals, Inc.
$518
ITI, Inc.
$468
Neurocrine Biosciences, Inc.
$466
Alkermes, Inc.
$426
Neos Therapeutics, LP
$308
Teva Pharmaceuticals USA, Inc.
$304
Bausch Health US, LLC
$242
Takeda Pharmaceuticals U.S.A., Inc.
$222
Tris Pharma Inc
$188
Brainsway USA INC
$184
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$173
Allergan Inc.
$169
Axsome Therapeutics, Inc.
$130
Avanir Pharmaceuticals, Inc.
$129
Allergan, Inc.
$99
Indivior Inc.
$88
Ironshore Pharmaceuticals Inc.
$74
Adlon Therapeutics L.P.
$64
Eisai Inc.
$58
Merck Sharp & Dohme Corporation
$47
IDORSIA PHARMACEUTICALS US INC
$47
Otsuka Pharmaceutical Development & Commercialization, Inc.
$46
ARBOR PHARMACEUTICALS, INC.
$44
JAZZ PHARMACEUTICALS INC.
$43
Orexo US, Inc.
$34
Jazz Pharmaceuticals Inc.
$30
Noven Therapeutics, LLC
$29
EISAI INC.
$22
OWP Pharmaceuticals, Inc.
$21
Avion Pharmaceuticals
$21
Azurity Pharmaceuticals, Inc.
$16
Top 3 companies account for 78.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · BrainsWay Deep TMS · CAPLYTA · COTEMPLA XR-ODT · Cotempla XR-ODT · Dayvigo · Dyanavel XR · EDARBYCLOR · Evekeo ODT · INGREZZA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · Methylphenidate Hydrochloride · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · Nuedexta · PERSERIS · QELBREE · QULIPTA · QUVIVIQ · Quillivant XR · REXULTI · SPRAVATO · SUBLOCADE · SUBVENITE · SUNOSI · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIIBRYD · VIVITROL · VRAYLAR · VYVANSE · WELLBUTRIN · XYREM · Xelstrym · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Allen?
Compare psychiatrists in the Allen area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
489
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL ALLEN
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ali is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ali experienced with magnetic field treatment to stimulate brain nerve cells?
Based on Medicare claims data, Dr. Ali performed 286 magnetic field treatment to stimulate brain nerve cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $50,217 from 41 companies across 716 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ali's costs compare to other psychiatrists in Allen?
Dr. Ali's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →